RePORT International Highlights

The Workshop will be held as a hybrid meeting from 4-5 December 2025, in San Francisco, US. The deadline for abstract submission is 5 September 2025.

APPLICATION DEADLINE: 1 December, 2025 11:59 p.m. ET The American Lung Association Catalyst Award is a mentored award meant to support outstanding investigators on the path to independence for research into the mechanisms of lung disease and general lung biology. Preference is given to projects that are novel, innovative in design/approach, utilize modern technologies, and incorporate a multidisciplinary collaborative training plan. The Catalyst Grant is for $50,000 per year, for up to two years. Grants are subject to annual review; the second year of support is based upon demonstration of satisfactory progress. When applicable, researchers are encouraged to investigate hypothesis‐driven research that will inform evidence‐based clinical practice or policy in communities across the United States. Proposals can include examining the cause and prevention of lung diseases like tuberculosis, asthma, COPD, and lung cancer, as well as management of lung disease.

The call for conference projects and publications covers all the thematic fields of the agency: - All research on HIV/AIDS, sexually transmitted infections (STIs), viral hepatitis, tuberculosis, including research on their co-infections; - Research on emerging and re-emerging infectious diseases, including arboviruses, respiratory viruses and viral hemorrhagic fevers. It is now possible to submit an application for funding continuously throughout the year, according to the following forecast schedule: January 15 – April 30 May 1 – August 31 September 1 – December 15

Deadline for Submissions: November 1, 2025 The Prize aims to recognize researchers who have developed innovative advances with translational potential to impact women’s health globally. Contributions within any area of women’s health* will be considered. These may cover work in areas of female-specific conditions including maternal health and chronic gynecological diseases, reproductive health including contraception and infertility affecting all persons, or elucidation of sex- and gender-specific approaches to conditions that affect women differently or disproportionately. We encourage researchers who may have made significant advances in addressing questions in these fields at the intersection of translational research and clinical applications, or who are developing new drugs, diagnostic approaches, medical devices, or healthcare technologies, to apply. Researchers who have advanced development of new solutions that can be readily deployed in low- and middle-income countries are encouraged to apply. The Prize is awarded for outstanding research performed by the applicant and as described in a 1,000-word essay.

The Career Award for Medical Scientists provides $700,000 awarded over five years for physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service.

Application Deadline: 7 October 2025 The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Please refer to the website for eligibility and details.

DEADLINE: 24 October, 2025 The Office of Disease Prevention Early Stage Investigator Lecture (ODP ESIL) award recognizes early career scientists who have made significant research contributions in prevention but who have not yet been awarded an R01 or R01-equivalent NIH research grant. In addition to meeting NIH's definition of an early stage investigator as of the nomination deadline, nominees should have: Innovative and significant research accomplishments in applied prevention research in humans, in areas that are relevant to ODP's mission Evidence of highly collaborative research projects, especially those that bridge disciplines to offer new approaches and ways of thinking in prevention research ODP is particularly interested in nominees conducting applied preventive intervention research to address common risk and protective factors for illness, injury, and the leading causes of death in the United States.

Submission Status: OPEN Submission Deadline: ONGOING Journal of Clinical Microbiology® (JCM) welcomes contributions to a Special Series on Diagnostic Testing for Mycobacteria. Tuberculosis is currently the world’s top infectious killer, and non-tuberculous mycobacteria (NTM) infections are also on the rise. Mycobacterial infections are more common in low-income nations and in patients with chronic health conditions. Accessible and accurate diagnosis of these infections is needed to guide effective treatment in these vulnerable patients. What We’re Looking for We welcome studies about the following: Inexpensive and accurate tests for tuberculosis, particularly tests that reduce the barriers of sputum-based diagnostics. Novel whole genome sequencing approaches to improve care of patients with tuberculosis through prediction of antimicrobial susceptibility and to improve rapid investigation of the spread of M. tuberculosis. Novel methods for rapid diagnostic testing for non-tuberculosis mycobacteria and for detection of antimicrobial resistance in mycobacteria (including non-tuberculosis and rapid-growing mycobacteria). Improved and novel diagnostics, including non-invasive tests, for extra-pulmonary tuberculosis. Suggested article types: Full-Length Text* New-Data Letter* Minireview** Commentary**

APPLICATION DEADLINE: 14 October 2025 17:00:00 Brussels time Objectives The Starting Grant supports excellent Principal Investigators starting or having recently started their own independent research team or programme. A Starting Grant Principal Investigator should have already shown evidence of the potential for research independence, for example, by having produced at least one important publication as its main author or a publication without the participation of their PhD supervisor. Size of ERC Starting Grants Starting Grants may be awarded up to a maximum of EUR 1 500 000 for a period of 5 years. The maximum size of the grants is reduced pro rata temporis for proposals of shorter duration. Profile of the ERC Starting Grant Principal Investigator The Principal Investigators shall have successfully defended their first PhD at least 2 and up to 7 years prior to 1 January 2026. Cut-off dates: Successful defence of PhD between 1 January 2019 and 31 December 2023 (inclusive). The eligibility period can be extended beyond 7 years in certain properly documented circumstances. See section 1.4 Admissibility, Eligibility, Resubmission Restrictions of the ERC Work Programme 2026.

APPLICATION DEADLINE: 05 November 2025 17:00:00 Brussels time Objective: The aim is to provide support for a small group of two to four Principal Investigators to jointly address ambitious research problems that could not be addressed by the individual Principal Investigators and their teams working alone. Synergy projects should enable substantial advances at the frontiers of knowledge, stemming, for example, from the cross-fertilization of scientific fields, from new productive lines of enquiry, or new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines. The transformative research funded by Synergy Grants should have the potential of becoming a benchmark on a global scale. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigators must also demonstrate that their group can successfully bring together the scientific elements necessary to address the scope and complexity of the proposed research question. One of the Principal Investigators must be designated as the Corresponding Principal Investigator. At any one time, one Principal Investigator per Synergy Grant Group except the Corresponding one can be hosted or engaged by an institution outside of the EU or Associated Countries. Size of ERC Synergy Grants Synergy Grants may be awarded up to a maximum of EUR 10 000 000 for a period of 6 years. The maximum award is reduced pro rata temporis for projects of a shorter duration. This does not apply to ongoing projects. Profile of the ERC Synergy Grant Principal Investigators The 'Synergy Grant Group' applying for the ERC Synergy Grant must be made up of a minimum of two and a maximum of four Principal Investigators with competitive track records and, as necessary, their teams. Each of the Principal Investigators must present in the proposal a Curriculum Vitae and a Track Record as appropriate to their career stage. For further information, please see the ERC Work Programme 2026.

APPLICATION DEADLINE: 31 October 2025 This recognises young investigators in the field of paediatric infectious diseases. Both clinical and basic research is eligible. The winner will receive: 1. Euro 5,000 to be paid to the host institution for research purposes only. The host institution is not allowed to take any overhead on this amount (see declaration below) 2. At the time of being offered the award successful candidates will be invited to attend that year's ESPID Annual Meeting with registration, travel and accommodation being offered (if already registered, this will be refunded). Please be aware the travel and accommodation are subject to ESPID Rules and maximum amounts apply 3. The Young Investigator's medal 4. The winner will be asked to give a 5 minute presentation of their work at the ESPID Annual Meeting

The JHU TRAC has partnered with RePORT International to offer Hopkins affiliates and their mentees the opportunity to enroll in JHU CANVAS asynchronous TB research courses. Select from the following courses: Epidemiology for TB Professional Development: Starting and Building Your Research Career Immunology for TB Introduction to Data Visualization Introduction to R Programming

RSTMH Global Research in Progress is an online meeting designed for early-career investigators worldwide to present and discuss their unpublished research with peers and senior experts in tropical medicine and global health. This meeting is free to attend for RSTMH members and Fellows, and just £10 for non-members.

Reviewers have a crucial role in ensuring that the research published in our journals, Transactions and International Heath, is novel, high quality, and accurate. Reviewing for the RSTMH journals allows you to contribute to the advancement of tropical medicine and global health while at the same time learning about the latest developments in the field before everyone else.

Date & time: 21 October 2025 | 10:00–14:00 UTC+1 This comprehensive workshop aims to provide participants with the skills, strategies, and insights needed to navigate the 2025–2026 funding landscape confidently. Expert-led sessions will cover key aspects of grant funding, from identifying opportunities to understanding what funders look for, plus a Q&A session. Whether you're new to grant writing or refining your approach, you'll learn how to find funders, align your project with their priorities, set clear objectives, build realistic budgets, and write effectively. The workshop will also cover collaborative proposals and community engagement. This workshop is organised by The Global Health Network for the Pathogen Variants Network, a global collaboration of six research teams funded by Wellcome to work on SARS-CoV-2. It is open to all for wider benefit and impact.

Date & time: 13 October 2025 | 10:00–11:30 UTC+1 Speakers: Michelle Clements (Chair, UK), Andrew Abaasa (Uganda), Philip Ayieko (Tanzania) and Vicky Simms (UK) Three Panel members working in Africa and the UK will be sharing their experiences of being trial statisticians, their challenges and top tips and having a discussion for the audience to join in.

The purpose of this notice of funding opportunity (NOFO) is to support the establishment of multidisciplinary Tuberculosis (TB) Research Units (TBRUs) that will operate as a collaborative network to improve understanding of Mycobacterium tuberculosis (Mtb)-host interactions through characterizing the roles of bacterial and host heterogeneity on infection outcomes and disease progression, and defining bacterial and host determinants relevant to Mtb establishment, dissemination, and disease stage. Please refer to the website for detail announcement and key dates.

The world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-21 November 2025.

APPLICATION DEADLINE: 19 October, 2025 The Harvard Global Health Institute is now accepting applications for our 2025-2026 cohort of Visiting Research Scholarship Program. Applications must be submitted by a Harvard faculty member, who will serve as the sponsor for an international research collaborator. This program provides funding for the Harvard sponsor to host their collaborator for a 6-week in-residence experience to complement ongoing research activities. Visiting scholars will have their in-residence time on campus financially covered through the fellowship award. Scholars will be provided with a lump sum stipend for their logistical expenses related to the visit (i.e. housing, flights to and from Cambridge, health insurance, J-1 visa fees, and daily per diem for food). The Harvard sponsor must be a Harvard faculty member at any school or affiliated hospital, and the visiting scholar should have a doctoral degree in a relevant degree. Demonstrated evidence of significant collaborative work with the sponsor, or the foundations for significant collaborative work, is required. This could be publications of peer-reviewed manuscripts, codeveloped educational curricula, partnership on policy, or service work.